Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors
Jensen Yeung, Ronald Vender, Irina Turchin, Rahul Shukla, Catherine Maari, Chih-ho Hong, Maxime Barakat, Perla Lansang
Topics & Concepts
MedicinePsoriasisInterleukin 17DermatologyInterleukinInternal medicineCytokinePsoriasis: Treatment and PathogenesisImmunodeficiency and Autoimmune DisordersPharmaceutical studies and practices